Search research articles
Contact Us
Filters
Showing results (361-370 of 391) with videos related to
Page
of 40
Sort By:
Plos One
|
April 30, 2024
Drug use and COVID-19 testing, vaccination, and infection among underserved, minority communities in Miami, Florida
Javier A Tamargo, Haley R Martin, Janet Diaz-Martinez, et al.
The Journal of Antimicrobial Chemotherapy
|
October 4, 2019
Long-term risk of hepatocellular carcinoma mortality in 23220 hospitalized patients treated with micafungin or other parenteral antifungals
Sebastian Schneeweiss, Peggy L Carver, Kausik Datta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1996
Adjuvant cyclophosphamide, methotrexate, and fluorouracil versus fluorouracil, epirubicin, and cyclophosphamide chemotherapy in premenopausal women with axillary node-positive operable breast cancer: results of a randomized trial. The International Collaborative Cancer Group
R C Coombes, J M Bliss, J Wils, et al.
JAMA Surgery
|
January 18, 2013
Postoperative antibacterial prophylaxis for the prevention of infectious complications associated with tube thoracostomy in patients undergoing elective general thoracic surgery: a double-blind, placebo-controlled, randomized trial
David A Oxman, Nicolas C Issa, Francisco M Marty, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 11, 2016
Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer
S Michiels, L Pugliano, S Marguet, et al.
Open Forum Infectious Diseases
|
October 11, 2021
Impact of Changes of the 2020 Consensus Definitions of Invasive Aspergillosis on Clinical Trial Design: Unintended Consequences for Prevention Trials?
John R Wingard, Barbara D Alexander, Lindsey R Baden, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 10, 2018
Safety and Efficacy of PD-1 Inhibitors Among HIV-Positive Patients With Non-Small Cell Lung Cancer
Lorena Ostios-Garcia, Jennifer Faig, Giulia C Leonardi, et al.
Breast (Edinburgh, Scotland)
|
October 8, 2013
Challenging single- and multi-probesets gene expression signatures of pathological complete response to neoadjuvant chemotherapy in breast cancer: experience of the REMAGUS 02 phase II trial
F Valet, P de Cremoux, F Spyratos, et al.
The Journal of Infectious Diseases
|
August 26, 2017
Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for Malignancy
Timothy J Henrich, Kristen S Hobbs, Emily Hanhauser, et al.
Open Forum Infectious Diseases
|
May 25, 2023
Effectiveness of Casirivimab and Imdevimab Antibody Combination in Immunocompromised Hospitalized Patients With Coronavirus Disease 2019: A Post Hoc Analysis in a Phase 1/2/3 Double-Blind Trial
Selin Somersan-Karakaya, Eleftherios Mylonakis, Jenni Mou, et al.
Page
of 40
Search research articles
Search
Showing results (361-370 of 391) with videos related to
Sort By:
Page
of 40
Plos One
|
April 30, 2024
Drug use and COVID-19 testing, vaccination, and infection among underserved, minority communities in Miami, Florida
Javier A Tamargo, Haley R Martin, Janet Diaz-Martinez, et al.
The Journal of Antimicrobial Chemotherapy
|
October 4, 2019
Long-term risk of hepatocellular carcinoma mortality in 23220 hospitalized patients treated with micafungin or other parenteral antifungals
Sebastian Schneeweiss, Peggy L Carver, Kausik Datta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1996
Adjuvant cyclophosphamide, methotrexate, and fluorouracil versus fluorouracil, epirubicin, and cyclophosphamide chemotherapy in premenopausal women with axillary node-positive operable breast cancer: results of a randomized trial. The International Collaborative Cancer Group
R C Coombes, J M Bliss, J Wils, et al.
JAMA Surgery
|
January 18, 2013
Postoperative antibacterial prophylaxis for the prevention of infectious complications associated with tube thoracostomy in patients undergoing elective general thoracic surgery: a double-blind, placebo-controlled, randomized trial
David A Oxman, Nicolas C Issa, Francisco M Marty, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 11, 2016
Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer
S Michiels, L Pugliano, S Marguet, et al.
Open Forum Infectious Diseases
|
October 11, 2021
Impact of Changes of the 2020 Consensus Definitions of Invasive Aspergillosis on Clinical Trial Design: Unintended Consequences for Prevention Trials?
John R Wingard, Barbara D Alexander, Lindsey R Baden, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 10, 2018
Safety and Efficacy of PD-1 Inhibitors Among HIV-Positive Patients With Non-Small Cell Lung Cancer
Lorena Ostios-Garcia, Jennifer Faig, Giulia C Leonardi, et al.
Breast (Edinburgh, Scotland)
|
October 8, 2013
Challenging single- and multi-probesets gene expression signatures of pathological complete response to neoadjuvant chemotherapy in breast cancer: experience of the REMAGUS 02 phase II trial
F Valet, P de Cremoux, F Spyratos, et al.
The Journal of Infectious Diseases
|
August 26, 2017
Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for Malignancy
Timothy J Henrich, Kristen S Hobbs, Emily Hanhauser, et al.
Open Forum Infectious Diseases
|
May 25, 2023
Effectiveness of Casirivimab and Imdevimab Antibody Combination in Immunocompromised Hospitalized Patients With Coronavirus Disease 2019: A Post Hoc Analysis in a Phase 1/2/3 Double-Blind Trial
Selin Somersan-Karakaya, Eleftherios Mylonakis, Jenni Mou, et al.
Page
of 40